<html>
<head>
<title>APORED-Grupos de Inmunolog&iacute;a - Departamento de Bioqu&iacute;mica, Biolog&iacute;a Molecular y Celular de la Universidad de Zaragoza</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<script language="JavaScript">
<!--
function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_findObj(n, d) { //v4.0
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && document.getElementById) x=document.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>

<style type="text/css">
A {
	TEXT-DECORATION: none
}
A:hover {
	COLOR: #999999; TEXT-DECORATION: underline
}
SELECT {
	BACKGROUND: #fce4d9; COLOR: #8f3670; FONT-FAMILY: Verdana; FONT-SIZE: 12px
}
INPUT {
	BACKGROUND: #fce4d9; COLOR: #8f3670; FONT-FAMILY: Verdana; FONT-SIZE: 12px
}
.headerlink {
	COLOR: #3366cc; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 9px; TEXT-DECORATION: none
}
.sublinks {
	COLOR: #666666; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 9px; TEXT-DECORATION: none
}
.seperator {
	COLOR: #000000; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 9px; TEXT-DECORATION: none
}
.sponsor {
	COLOR: orange; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 9px; TEXT-DECORATION: none
}
.links {
	COLOR: #666666; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 9px; MARGIN-LEFT: 20px; TEXT-DECORATION: none
}
.a {
	COLOR: #666666; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 9px; MARGIN-LEFT: 20px; TEXT-DECORATION: none
}
.navform {
	COLOR: #f8c8b3; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 10px; TEXT-DECORATION: none
}
.globalcom {
	COLOR: #8f3670; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 10px; TEXT-DECORATION: none
}
.globalcomlink {
	COLOR: #8f3670; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 10px; TEXT-DECORATION: underline
}
.date {
	COLOR: #ff9900; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 10px; TEXT-DECORATION: none
}
.pestana {
	COLOR: #8f3670; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 12px
}
.pestanaon {
	COLOR: #f8c8b3; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 12px; TEXT-DECORATION: none
}
.line {
	COLOR: #666666; FONT-FAMILY: Verdana, Arial, Helvetica, sans-serif; FONT-SIZE: 12px
}
  
 
.Estilo1 {
	font-size: 12px;
	font-family: "Arial Narrow", Arial;
	font-weight: bold;
	font-style: italic;
	color: #FF3300;
}
.Estilo2 {
	font-size: 14px;
	color: #663300;
}
.Estilo4 {font-size: 14px}
.Estilo6 {color: #663300}
.Estilo8 {
	font-family: "Arial Narrow", Arial;
	font-size: 14px;
}
.Estilo9 {
	font-family: "Arial Narrow", Arial;
	font-size: 14px;
	font-weight: bold;
	color: #009999;
}
.Estilo10 {color: #006666}
.Estilo15 {
	color: #009966;
	font-weight: bold;
}
.Estilo16 {color: #009966}
.Estilo17 {color: #000000}
.Estilo18 {font-weight: bold}
.Estilo19 {
	font-family: "Arial Narrow", Arial;
	font-size: 12px;
}
.Estilo20 {font-family: "Arial Narrow", Arial}
.Estilo21 {
	font-size: 16px;
	font-weight: bold;
	color: #009999;
}
.Estilo22 {color: #FF0000}
.Estilo23 {color: #FF3300}
body {
	background-color: #CCCCCC;
}
.Estilo24 {color: #0099FF}
</style>



</head>

<body text="#000000" leftmargin="0" topmargin="0" marginwidth="0" onLoad="MM_preloadImages('probando/bp_03-on.gif','probando/bp_04-on.gif','probando/bp_o05-on.gif','Imagenes/nerdes_on.gif','Imagenes/otroson.gif','Imagenes/todoson.gif','probando/bp_02-on.gif','Imagenes/arribaaron.jpg')" marginheight="0">
<div align="center">
  <table border="0" bgcolor="#009999" cellspacing="0" cellpadding="0" width="762">
    <tr> 
      <td align="left" bgcolor="#009999" width="176"><img src="probando/aporedprob02.jpg" width="142" height="62" usemap="#Map5" border="0"><a name="subir"></a></td>
      <td align="center" bgcolor="#009999"><object classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=5,0,0,0" width="550" height="62">
          <param name=movie value="aporedbrillo.swf">
          <param name=quality value=high>
          <embed src="aporedbrillo.swf" quality=high pluginspage="http://www.macromedia.com/shockwave/download/index.cgi?P1_Prod_Version=ShockwaveFlash" type="application/x-shockwave-flash" width="550" height="62">
          </embed> 
        </object></td>
    </tr>
  </table>
  <table width="762" border="0" cellspacing="0" cellpadding="0" bgcolor="#009999">
    <tr> 
      <td height="28" valign="top" align="left" bgcolor="#009999"><img src="Imagenes/lineintegrantes.gif" width="741" height="32" usemap="#Map4" border="0"></td>
    </tr>
  </table>
  <table border="0" cellspacing="0" cellpadding="0" bgcolor="#009999">
    <tr> 
      <td><img name="Image3" border="0" width="153" height="25" src="probando/bp_01-on.gif"><br>
      </td>
      <td valign="top"><a href="divulgacion.htm" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('Image25','','probando/bp_02-on.gif',1)"><img name="Image25" border="0" src="probando/bp_02-off.gif" width="153" height="25"></a></td>
      <td valign="top"><a href="investigacion.htm" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('Image26','','probando/bp_03-on.gif',1)"><img name="Image26" border="0" src="probando/bp_03-off.gif" width="153" height="25"></a></td>
      <td valign="top"><a href="eventos.htm" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('Image27','','probando/bp_04-on.gif',1)"><img name="Image27" border="0" src="probando/bp_04-off.gif" width="153" height="25"></a></td>
      <td valign="top"><a href="enlaces.htm" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('Image28','','probando/bp_o05-on.gif',1)"><img name="Image28" border="0" src="probando/bp_05-off.gif" width="150" height="25"></a></td>
    </tr>
  </table>
  <table width="763" border="0" cellpadding="0" cellspacing="0">
    <tr> 
      <td valign="middle" colspan="8" bordercolor="0" bgcolor="#000000" align="right"><img src="Imagenes/mapa.gif" width="42" height="25" usemap="#Map8" border="0"></td>
      <td width="1"></td>
    </tr>
    <tr> 
      <td valign="middle" rowspan="7" width="101" bgcolor="#000000" align="center"><img src="Imagenes/fasL-01.jpg" width="100" height="87" alt="Comentario"></td>
      <td valign="bottom" bordercolor="0" colspan="4" rowspan="3" bgcolor="#000000"><font face="Arial, Helvetica, sans-serif" size="4" color="#660033"><b><font color="#993300" face="Arial Narrow">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Apoptosis, 
        Inmunidad y Cancer</font></b></font> 
        <hr noshade>
      </td>
      <td valign="top" colspan="3" bgcolor="#000000" align="center"><font color="#FFFFFF" face="Arial Narrow" size="1">Apoptosis 
        en</font></td>
      <td></td>
    </tr>
    <tr> 
      <td valign="top" colspan="3" align="right" bgcolor="#000000"><object classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=5,0,0,0" width="95" height="15">
          <param name="BGCOLOR" value="#000000">
          <param name="BASE" value=".">
          <param name=movie value="sistemainmune.swf">
          <param name=quality value=high>
          <embed src="sistemainmune.swf" quality=high pluginspage="http://www.macromedia.com/shockwave/download/index.cgi?P1_Prod_Version=ShockwaveFlash" type="application/x-shockwave-flash" width="95" height="15" bgcolor="#000000" base=".">
          </embed> 
        </object></td>
      <td></td>
    </tr>
    <tr> 
      <td valign="top" align="right" colspan="3" rowspan="2" bgcolor="#000000"><object classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=4,0,2,0" width="129" height="17">
          <param name="BASE" value=".">
          <param name=movie value="nerde.swf">
          <param name=quality value=high>
          <param name="BGCOLOR" value="#000000">
          <param name="SCALE" value="exactfit">
          <embed src="nerde.swf" quality=high pluginspage="http://www.macromedia.com/shockwave/download/index.cgi?P1_Prod_Version=ShockwaveFlash" type="application/x-shockwave-flash" scale="exactfit" width="129" height="17" bgcolor="#000000" base=".">
          </embed> 
        </object></td>
      <td></td>
    </tr>
    <tr> 
      <td valign="middle" align="center" colspan="4" rowspan="4" bgcolor="#000000"><font face="Tw Cen MT, Arial Narrow" color="#660033" size="2"><b><font size="4" face="Arial, Helvetica, sans-serif" color="#FF9900"> 
        &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font face="Geneva, Arial, Helvetica, san-serif">&nbsp;<font color="#FF6600">Departamento 
        de Bioquimica,Biologia Molecular y Celular de la Universidad de Zaragoza</font></font></font></b></font></td>
      <td></td>
    </tr>
    <tr> 
      <td valign="top" colspan="3" align="right" bgcolor="#000000"><object classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=4,0,2,0" width="42" height="15">
          <param name=movie value="cancer.swf">
          <param name=quality value=high>
          <param name="BASE" value=".">
          <param name="BGCOLOR" value="#000000">
          <param name="SCALE" value="exactfit">
          <embed src="cancer.swf" base="."  quality=high pluginspage="http://www.macromedia.com/shockwave/download/index.cgi?P1_Prod_Version=ShockwaveFlash" type="application/x-shockwave-flash" scale="exactfit" width="42" height="15" bgcolor="#000000">
          </embed> 
        </object></td>
      <td></td>
    </tr>
    <tr> 
      <td valign="top" colspan="3" align="right" bgcolor="#000000"><object classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=4,0,2,0" width="88" height="15">
          <param name=movie value="otross.swf">
          <param name=quality value=high>
          <param name="BASE" value=".">
          <param name="BGCOLOR" value="#000000">
          <param name="SCALE" value="exactfit">
          <embed src="otross.swf" base="."  quality=high pluginspage="http://www.macromedia.com/shockwave/download/index.cgi?P1_Prod_Version=ShockwaveFlash" type="application/x-shockwave-flash" scale="exactfit" width="88" height="15" bgcolor="#000000">
          </embed> 
        </object></td>
      <td></td>
    </tr>
    <tr> 
      <td valign="top" colspan="3" align="right" bgcolor="#000000"><object classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=4,0,2,0" width="37" height="15">
          <param name=movie value="todios.swf">
          <param name=quality value=high>
          <param name="BASE" value=".">
          <param name="BGCOLOR" value="#000000">
          <param name="SCALE" value="exactfit">
          <embed src="todios.swf" base="."  quality=high pluginspage="http://www.macromedia.com/shockwave/download/index.cgi?P1_Prod_Version=ShockwaveFlash" type="application/x-shockwave-flash" scale="exactfit" width="37" height="15" bgcolor="#000000">
          </embed> 
        </object></td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="8" valign="top"> 
        <hr>
      </td>
      <td></td>
    </tr>
    <tr> 
      <td valign="top" colspan="2" rowspan="2" bgcolor="#000000"> 
        <div align="center"> 
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#336633"><br>
            </font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#336633"><a href="#c"><font color="#000000"><b><font color="#FFFFFF">Miembros</font></b></font></a><br>
            <a href="#a"><font color="#33CCFF"><b><font color="#FFFFFF">L&iacute;neas 
            Investig.</font></b></font></a><br>
            <a href="#b"><font color="#000000"><b><font color="#FFFFFF">Publicaciones</font></b></font></a><br>
            <a href="#d"><font color="#000000"><b><font color="#FFFFFF">Proyectos</font><font color="#009999"><br>
            </font></b></font></a><a href="#e"><font color="#000000"><b><font color="#FFFFFF">Tesis 
            Doctorales</font></b></font></a><br>
            <a href="http://apored.rediris.es/investigacion02.htm#aa"><font color="#FFFFFF"><b><font color="#CCCCCC">Im&aacute;genes</font></b></font></a> 
            </font></p>
        </div>
      </td>
      <td valign="top" rowspan="15" background="probando/fondo negro.gif" width="8">&nbsp;</td>
      <td width="400" valign="top" background="fondogris.jpg"> 
        <blockquote> 
          <p>&nbsp;</p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><b><font size="3">Grupo 
            coordinado por los Drs. Maria Angeles Alava, Alberto Anel y Javier 
            Naval.</font></b></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="3" color="#009999"><b><font color="#006666">Departamento 
            de <br>
            Bioquimica, Biologia Molecular y Celular.<br>
            Facultad de Ciencias<br>
            Universidad de Zaragoza.<br>
            Zaragoza. 50009 SPAIN</font></b></font></p>
          <p align="center" class="Estilo1"> Reconocido como Grupo de Excelencia Investigadora <br>
          por el Gobierno de Arag&oacute;n (2005) </p>
          <p><font color="#009999" face="Tw Cen MT, Arial Narrow" size="2"><a href="http://www.bioq.unizar.es" target="_blank"><font color="#663300" size="3"><b>http://www.bioq.unizar.es/</b></font></a><br>
            <font color="#000000"><b>e-mail:</b></font></font> <a href="mailto:anel@posta.unizar.es"><font color="#663300" face="Tw Cen MT, Arial Narrow" size="2">anel@posta.unizar.es</font></a><font color="#000000" face="Tw Cen MT, Arial Narrow" size="2"><br>
            Tph : 34-976-761279<br>
            Fax : 34-976-762123</font><font color="#009999" face="Tw Cen MT, Arial Narrow" size="2"><br>
            </font><a name="c"></a><br>
            <font face="Tw Cen MT, Arial Narrow" size="3" color="#3399FF"><b><font face="Tw Cen MT, Arial Narrow" size="3" color="#3399FF"><b></b></font></b></font> 
          </p>
        </blockquote>
      </td>
      <td valign="middle" colspan="2" align="center" background="fondogris.jpg"><div align="left"><img src="Imagenes/FasL-03.jpg" width="176" height="308" alt="Secreci&oacute;n de FasL tras activaci&oacute;n de blastos T"><br>
            <font face="Tw Cen MT, Arial Narrow, Arial" size="1"><b><font color="#333333">Secreci&oacute;n 
        de FasL tras activaci&oacute;n de blastos T </font></b></font></div></td>
      <td rowspan="15" width="13" valign="top" background="Imagenes/transazul.gif">&nbsp;</td>
      <td width="34" rowspan="15" valign="top" bgcolor="#009999">&nbsp;</td>
      <td></td>
    </tr>
    <tr> 
      <td valign="top" colspan="3" rowspan="14" background="fondogris.jpg"> 
        <blockquote> 
          <hr noshade>
          <font face="Tw Cen MT, Arial Narrow" size="3" color="#3399FF"><b><font face="Tw Cen MT, Arial Narrow" size="3" color="#3399FF"><b></b></font></b></font> 
          <p><span class="Estilo24"><font face="Tw Cen MT, Arial Narrow" size="3"><b><font size="4">Miembros 
            del grupo</font></b></font></span><font face="Tw Cen MT, Arial Narrow" size="2"></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"><br>
            <font color="#336666" size="3"><b><br>
            </b></font></font><font face="Tw Cen MT, Arial Narrow" size="2"><font size="3"><b><span class="Estilo16"><font size="2">Responsables</font></span></b></font></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"><font color="#336666" size="3"><b><br>
            Dr. Alberto Anel<br>
            </b></font><font color="#000000" face="Tw Cen MT, Arial Narrow" size="2"><b>e-mail 
            :</b></font> <a href="mailto:anel@posta.unizar.es"><font color="#663300" face="Tw Cen MT, Arial Narrow" size="2">anel@posta.unizar.es</font></a><font color="#336666" size="3"><b> 
            <br>
            Dr. Javier Naval<br>
            </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"><font color="#000000" face="Tw Cen MT, Arial Narrow" size="2"><b>e-mail 
            :</b></font> </font><font color="#336666" size="3"><font color="#99CC00"><a href="mailto:jnaval@posta.unizar.es"><font color="#663300" size="2">jnaval@posta.unizar.es</font></a></font><b> 
            <br>
            Dr. Maria &Aacute;ngeles &Aacute;lava<br>
          </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"><font color="#000000" face="Tw Cen MT, Arial Narrow" size="2"><b>e-mail :</b></font> </font></font><font face="Tw Cen MT, Arial Narrow"><a href="mailto:malava@posta.unizar.es" class="Estilo2">malava@posta.unizar.es</a></font></p>
          <p>&nbsp;          </p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"><font color="#336666" size="3"><b>Dr. Andres Pi&ntilde;eiro<br>
            </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"><font color="#000000" face="Tw Cen MT, Arial Narrow" size="2"><b>e-mail : </b></font></font></font> </font><span class="Estilo4"><font face="Tw Cen MT, Arial Narrow"><a href="mailto:pineiro@posta.unizar.es" class="Estilo6">pineiro@posta.unizar.es</a></font></span><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"><font color="#336666" size="3"><b> <br>
            Dr. Fermin Lampreave<br>
            </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"><font color="#000000" face="Tw Cen MT, Arial Narrow" size="2"><b>e-mail : </b></font></font></font><font face="Tw Cen MT, Arial Narrow" size="2"><font face="Tw Cen MT, Arial Narrow" size="2"><font face="Tw Cen MT, Arial Narrow" size="2"><font face="Tw Cen MT, Arial Narrow" size="2"><font face="Tw Cen MT, Arial Narrow" size="2"><a href="mailto:lampreav@posta.unizar.es" class="Estilo6">lampreav@posta.unizar.es</a></font></font></font></font></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"> <font color="#336666" size="3"><b><br>
            Dra. Maria Iturralde<br>
            </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"><font color="#000000" face="Tw Cen MT, Arial Narrow" size="2"><b>e-mail : 
    

                                                                                                                                                                </b></font></font></font><font face="Tw Cen MT, Arial Narrow" size="2"><font face="Tw Cen MT, Arial Narrow" size="2"><font face="Tw Cen MT, Arial Narrow" size="2"><b><a href="mailto:miturral@posta.unizar.es" class="Estilo6">miturral@posta.unizar.es</a></b></font></font></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033">
    
                                                                                                                                                            <font color="#336666" size="3"><b><br>
                Dra. Isabel Marzo<br>
                                                                                                                                                            </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"><font color="#000000" face="Tw Cen MT, Arial Narrow" size="2"><b>e-mail :</b></font> </font></font><font face="Tw Cen MT, Arial Narrow"><font face="Tw Cen MT, Arial Narrow"><a href="mailto:imarzo@posta.unizar.es" class="Estilo2">imarzo@posta.unizar.es</a></font></font></p>
          <p>&nbsp;</p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2"><span class="Estilo15">Becarios 
                  : </span></font><font face="Tw Cen MT, Arial Narrow" size="2"></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#336666"><br>
                  <font color="#009999"><b><font size="3">&gt; Alberto Bosque</font></b></font><br>
                  <font color="#000000"><b>e-mail:</b></font> <a href="mailto:abosque@posta.unizar.es"><font color="#663300">abosque@posta.unizar.es</font></a><br>
                  <br>
                  <i><font face="Times New Roman, Times, serif"><b><font color="#000000">R:</font></b><font color="#000000"> Los objetivos de mi memoria de Tesis:<br>
            </font></font></i></font><span class="Estilo8">1.- Estudiar utilizando microscopia confocal y electr&oacute;nica la localizaci&oacute;n de FasL y APO2L/TRAIL en c&eacute;lulas T humanas y la forma en la que estas prote&iacute;nas son secretadas durante la AICD inducida por PHA, anticuerpos anti-CD3 o anticuerpos anti-CD59. <br>
            2.- Caracterizaci&oacute;n de la composici&oacute;n proteica y lipidica de las microvesiculas secretadas durante la AICD inducida por los estimulos descritos en el punto anterior.<br>
          3.- Caracterizar en detalle la implicaci&oacute;n de FasL, APO2L, TNF u otras mol&eacute;culas citot&oacute;xicas en la AICD de blastos T humanos, diferenciando entre c&eacute;lulas CD4+ y CD8+ </span> </p>
          <p><font face="Tw Cen MT, Arial Narrow, Arial" size="3" color="#336666"><b><font color="#009999">&gt; Clara 
            Diestre Mart&iacute;n</font></b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#336666"><br>
            </font><span class="Estilo18"><font face="Tw Cen MT, Arial Narrow" size="2"><span class="Estilo17">e-mail: </span></font></span><font face="Tw Cen MT, Arial Narrow" size="2" color="#336666"><a href="mailto:cdiestre@hotmail.com"><font color="#663333">cdiestre@hotmail.com<br>
            </font></a><i><font face="Times New Roman, Times, serif"><b><font color="#000000">R:</font></b><font color="#000000"> Los objetivos de mi memoria de Tesis:</font></font></i><br>
            </font><span class="Estilo8">1.- Producci&oacute;n de antisueros anti-FasL, APO2L/TRAIL y APO3L/TWEAK por inyecci&oacute;n intramuscular de cDNA <br>
            2.- Caracterizaci&oacute;n de un segundo receptor para APO3L/TWEAK </span></p>
          <p class="Estilo9">&gt; Mar&iacute;a G&oacute;mez-Benito, <span class="Estilo10">becaria FPU<br>
          </span>&gt; Nuria L&oacute;pez-Royuela, <span class="Estilo10">becaria Redes FIS<br>
          </span>&gt; Patricia Balsas, <span class="Estilo10">becaria FIS<br>
          </span>&gt; Idoia Alonso, <span class="Estilo10">becaria DGA<br>
          </span>&gt; Jos&eacute; Ignacio Aguil&oacute;, <span class="Estilo10">becario FPI<br>
          </span>&gt; Rakel Carpintero, <span class="Estilo10">becaria Fundaci&oacute;n Cuenca-Villoro<br>
          </span>&gt; Marta Andr&eacute;s, <span class="Estilo10">contrato OTRI </span></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#336666"><br>
            </font><font face="Tw Cen MT, Arial Narrow" size="2" color="#336666"> </font><font face="Tw Cen MT, Arial Narrow" size="2" color="#336666"><b>Miembros 
              del grupo de otros centros</b><br>
            Servicio de Inmunologia del Hospital Clinico Universitario &quot;Lozano 
              Blesa&quot; / Instituto Aragon&eacute;s de Ciencias de la Salud (IACS) :<br>
            <b><font size="3" color="#003399"><a href="mjml.htm"><font color="#006666">Drs. Luis Larrad, Pilar Lasierra y Mar&iacute;a Jos&eacute; Mart&iacute;nez-Lorenzo<br>
            Becarias: Berta S&aacute;ez, becaria FIS; Mar&iacute;a Royo, becaria Redes FIS</font></a></font></b></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#336666">Departamento 
              de Hematologia del Hospital Miguel Servet : <br>
            <b><font size="3">Drs. Pilar Giraldo y Daniel Rubio-Felix.</font></b></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#336666">Max-Planck Institut f&uuml;r Immunbiologie, Freiburg, Alemania <br>
              <b><font size="3">Dr. Juli&aacute;n Pardo <br>
          </font><font face="Tw Cen MT, Arial Narrow" size="2" color="#336666"><font color="#000000"><b>e-mail:</b></font> </font></b></font><span class="Estilo4"><font face="Tw Cen MT, Arial Narrow"><a href="email:pardojim@unizr.es" class="Estilo6">pardojim@unizr.es</a></font></span></p>
          <p>&nbsp;</p>
          <p align="right"><font face="Tw Cen MT, Arial Narrow" size="4" color="#660033"><b></b></font><font face="Tw Cen MT, Arial Narrow" size="4" color="#660033"><b><font face="Tw Cen MT, Arial Narrow" size="2" color="#660033"><a name="a"></a></font></b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#336666"><a href="#subir"><img src="probando/arriba.gif" width="15" height="21" border="0" usemap="#Map2"></a></font></p>
          <hr noshade>
          <font face="Tw Cen MT, Arial Narrow" size="4" color="#660033"><b></b></font> 
          <font face="Tw Cen MT, Arial Narrow" size="4" color="#660033"><b></b></font> 
          <p class="Estilo24"><font face="Tw Cen MT, Arial Narrow" size="4"><b>L&iacute;neas 
            de Investigaci&oacute;n</b></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="3" color="#000066">1.- 
            Papel de receptores y ligandos de muerte en la muerte inducida por<br>
            activacion de celulas T humanas. Aplicacion al estudio de enfermedades<br>
            autoinmunes.</font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="3" color="#000066">2.- 
            Caracterizacion de las rutas de apoptosis en neoplasias hematologicas<br>
            humanas. Aplicacion a la identificacion de nuevos factores de pronostico 
            y<br>
            mejora del tratamiento de la leucemia linfatica cronica de celulas 
            B<br>
            (LLC-B) y al mieloma multiple (MM).</font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="3" color="#000066">3.- 
            Mecanismos citoliticos de los linfocitos T citotoxicos y las celulas 
            NK: ligando de Fas (FasL), perforina/granzimas, granulisina.</font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="3" color="#000066">4.- 
            Caracterizacion molecular de las alteraciones en los procesos de<br>
            se&ntilde;alizacion en lineas celulares resistentes a la apoptosis 
            con fenotipo<br>
            altamente proliferativo, generadas a partir de la leucemia humana 
            Jurkat.</font></p>
          <p align="right"><font face="Tw Cen MT, Arial Narrow" size="4" color="#660033"><a name="b"></a></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#336666"><a href="#subir"><img src="probando/arriba.gif" width="15" height="21" border="0" usemap="#Map3"></a></font></p>
          <hr>
          <p><font face="Tw Cen MT, Arial Narrow" size="4"><span class="Estilo24"><b>Publicaciones 
            en relaci&oacute;n con las l&iacute;neas de Investigaci&oacute;n</b><br>
            <font size="2">(&Uacute;ltimos 5 a&ntilde;os)</font></span></font></p>
          <p class="Estilo19">(Los pdf de estas nuevas publicaciones han sido a&ntilde;adido en la p&aacute;gina BSCW con el t&iacute;tulo que se indica entre par&eacute;ntesis) </p>
          <p><font face="Tw Cen MT, Arial Narrow" size="3" color="#000033"><b>LINEA 
            1.</b></font></p>
          <p class="Estilo4 Estilo20"><strong>Mart&iacute;nez-Lorenzo, M.J., Anel, A., Pi&ntilde;eiro, A., Naval, J., Alava, M.A., Lasierra, P. y Larrad, L. </strong><br>
            <span class="Estilo21">The human melanoma cell line MelJuso secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles. Contribution to tumor counterattack. </span><br>
          Exp. Cell Res., 295 : 315-329. 2004. (<span class="Estilo22">Martinez-Lorenzo.04.Exp. Cell Res.</span>)</p>
          <p class="Estilo8"><strong>Bosque, A., Pardo, J., Mart&iacute;nez-Lorenzo, M.J., Iturralde, M., Marzo, I., Pi&ntilde;eiro, A., Alava, M.A., Naval, J. y Anel, A. </strong><br>
            <span class="Estilo21">Downregulation of normal human T cell blasts activation: roles of APO2L/TRAIL, FasL and of c- FLIP, Bim and Bcl-x isoform expression. </span><br>
          J. Leukoc. Biol., 77: 568-578. 2005. (Bosque.05.J. Leukoc. Biol.)</p>
          <p class="Estilo8"><strong>Bosque, A., Mart&iacute;nez-Lorenzo, M.J., Lasierra, P., Larrad, L., Marzo, I., Naval, J. y Anel, A. </strong><br>
            <span class="Estilo21">Human CD8 + are more sensitive than CD4 + T cell blasts to regulation by APO2L/TRAIL. </span><br>
          Eur. J. Immunol., en prensa, 2005. </p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>Mart&iacute;nez-Lorenzo, M.J., Alava, M.A., Gamen, S., Kim, K.J., 
              Chuntharapai,<br>
            A., Pi&ntilde;eiro, A., Naval, J. y Anel, A. </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><br>
            <b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">Involvement 
              of APO2 ligand/TRAIL in activation-induced death of Jurkat and human 
            peripheral blood T cells. </font></b><br>
            <font color="#000000">Eur. J. Immunol., 28 : 2714-2725. 1998</font>.</font><font face="Tw Cen MT, Arial Narrow" size="2" color="#0033CC"> 
            <font color="#FF6633"><a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860"><font color="#FF3300">pdf 
            &quot;APO2L&quot;</font></a></font></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>Mart&iacute;nez-Lorenzo, M.J., Anel, A., Gamen, S., Monle&oacute;n, 
            I., Lasierra,<br>
            P., Larrad, L., Pi&ntilde;eiro, A., Alava, M.A. y Naval, J.</b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"> 
            <br>
            <b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">Activated 
            human T cells release bioactive Fas ligand and APO2 ligand in microvesicles</font></b><br>
            <font color="#000000">J. Immunol., 163 : 1274-1281, 1999.</font> <a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860"><font color="#FF6600">pdf 
            &quot;Martinez-Lorenzo&quot;</font></a></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>Anel, A., Mart&iacute;nez-Lorenzo, M.J., Monle&oacute;n, I., Pi&ntilde;eiro, 
            A., Naval, J. y<br>
            Alava, M.A. </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><br>
            <b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">Activation-induced 
            death of human T cells mediated by Fas ligand and APO2 ligand</font></b><br>
            en <font color="#000000">&quot;Recent Research Developments in Immunology&quot;, 
            vol. 1 (Pandalai, S.G., ed.). pp. 63-73. Research Signpost. Trivandrum 
            1999</font></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>Monle&oacute;n, I., Mart&iacute;nez-Lorenzo, M.J., Anel, A., Lasierra, 
            P., Larrad, L.,<br>
            Pi&ntilde;eiro, A., Naval, J. y Alava, M.A.</b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"> 
            <br>
            <font face="Times New Roman, Times, serif"><b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">CD59 
            cross-linking induces secretion of APO2 ligand in overactivated human 
            T cell</font></b></font><br>
            <font color="#000000">Eur. J. Immunol., 30:1078-1087, 2000</font></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000">.</font><font face="Tw Cen MT, Arial Narrow" size="2" color="#0033CC"> 
            <font color="#FF6600"><a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860"><font color="#FF6633">pdf 
            &quot;CD59&quot;</font></a></font></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>Monle&oacute;n, I., Mart&iacute;nez-Lorenzo, M.J., Monteagudo, L., 
            Lasierra, P.,<br>
            Taul&eacute;s, M., Iturralde, M., Pi&ntilde;eiro, A., Larrad, L., 
            Alava, M.A., Naval, J.<br>
            y Anel, A. </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><br>
            <b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">Differential 
            secretion of Fas ligand or APO2 ligand/TRAIL-carrying microvesicles 
            during activation-induced death of human T cells. </font></b><br>
            <font color="#000000">J. Immunol., 167 : 6736-6744. 2001</font>.</font><font face="Tw Cen MT, Arial Narrow" size="2" color="#0033CC"> 
            <a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860"><font color="#FF6600">pdf 
            &quot;Monleon&quot;</font></a></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#003366"><b><font size="3">LINEA 
            2</font></b></font></p>
          <p class="Estilo20 Estilo4"><strong>Marzo, I., P&eacute;rez-Gal&aacute;n, P., L&oacute;pez-Royuela, N., G&oacute;mez-Benito, M., Larrad, L., Lasierra, P., Giraldo, P., Rubio-F&eacute;lix, D., Anel, A . y Naval, J. </strong><br>
            <span class="Estilo21">The farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-CLL cells resistant to nucleoside analogues. </span><br>
          Leukemia, 18 : 1599-1604. 2004 (<span class="Estilo23">Marzo.04.Leukemia</span>) </p>
          <p class="Estilo8"><strong>Naval, J., Marzo, I. y Anel, A. </strong><br>
            <span class="Estilo21">Mecanismos celulares de la muerte celular programada. </span><br>
          Hematologica., 89: 127-133. 2004. </p>
          <p class="Estilo8"><strong>G&oacute;mez-Benito, M., Marzo, I., Anel, A . y Naval, J. </strong><br>
            <span class="Estilo21"><strong>Apoptosis induced by farnesyltransferase inhibition. Initiation by conformational changes of Bax and Bak and Mcl-1 elimination and execution by caspases and AIF. </strong></span><br>
          Mol. Pharmacol., en prensa, 2005. </p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><b><font color="#000000">Gamen, S., Anel, A., Lasierra, P., Alava, M.A., Martinez-Lorenzo, 
            M.J.,<br>
            Pi&ntilde;eiro, A. and Naval, J. </font></b><br>
            <font face="Times New Roman, Times, serif"><b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">Doxorubicin-induced 
              apoptosis in human T-cell leukemia is mediated by caspase-3 activation 
            in a Fas-independent way.</font></b></font><br>
            <font color="#000000">FEBS Lett., 417 : 360-364, 1997</font>. <a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860" target="_blank"><font color="#FF6600">pdf 
            &quot;DOX&quot;</font></a></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>Gamen, S., Anel, A., Pi&ntilde;eiro, A. y Naval, J. </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><br>
            <font face="Times New Roman, Times, serif"><b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">Caspases 
            are the main executioners of Fas-mediated apoptosis, irrespective 
            of the ceramide pathway. </font></b></font><br>
            <font color="#000000">Cell Death Differ., 5 : 241-249, 1998</font></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#0033CC">. 
            <a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860" target="_blank"><font color="#FF6600">pdf 
            &quot;Ceramide&quot;</font></a></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>Gamen, S., Anel, A., P&eacute;rez-Gal&aacute;n, P., Lasierra, P., 
            Johnson, D.E.,<br>
            Pi&ntilde;eiro, A. y Naval, J. </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><br>
            <b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">Doxorubicin 
            treatment activates a Z-VAD sensitive caspase, which causes <font face="Arial, Helvetica, sans-serif">&#144;</font>Ym 
            loss, caspase-9 activity and apoptosis in Jurkat cells. </font></b><br>
            <font color="#000000">Exp. Cell Res., 258 : 223-235, 2000.</font></font></p>
          <p><font face="Times New Roman, Times, serif" size="2" color="#000000"><b><font face="Tw Cen MT, Arial Narrow, Arial">Marzo, I., P&eacute;rez-Gal&aacute;n, P., Giraldo, P., Rubio-F&eacute;lix, 
            D., Anel, A. y Naval, J. </font></b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><br>
            <b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">Cladribine 
            induces apoptosis in human leukemia cells by caspase-dependent and 
            independent pathways acting on mitochondria. </font></b><br>
            <font color="#000000">Biochem. J., 359 : 537-546. 2001</font>.</font><font face="Tw Cen MT, Arial Narrow" size="2" color="#0033CC"> 
            <a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860"><font color="#FF6600">pdf 
            &quot;Marzo&quot;</font></a></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>P&eacute;rez-Gal&aacute;n, P., Marzo, I., Giraldo, P., Rubio-F&eacute;lix, 
            D., Lasierra, P., Larrad, L., Anel, A. y Naval, J. </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#0033CC"><br>
            <b><font size="3" color="#009999">Role of caspases and apoptosis-inducing 
            factor (AIF) in cladribine-induced apoptosis of B-cell chronic lymphocytic</font> 
            <font color="#009999" size="3">leukemia. </font><br>
            </b> <font color="#000000">Leukemia, 16 : 2106-2114, 2002. </font></font><font face="Tw Cen MT, Arial Narrow" size="2"><span class="Estilo23">pdf 


 P&eacute;rez-Gal&aacute;n.02.Leukemia</span></font> </p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#0033CC"><b><font color="#003366" size="3">LINEA 
            3</font></b></font></p>
          <p class="Estilo8"><strong>Iturralde, M., Gamen, S., Pardo, J., Barrio, G., Pi&ntilde;eiro, A., Alava, M.A., Naval, J. y Anel, A. </strong><br>
            <span class="Estilo21">Saturated free fatty acids release and intracellular ceramide generation during apoptosis induction are closely related processes . </span><br>
          Biochim. Biophys. Acta, 1634 : 40-51, 2003. (<span class="Estilo23">Iturralde.03.BBA</span>)</p>
          <p class="Estilo8"><strong>Pardo, J., Buferne, M., Mart&iacute;nez-Lorenzo, M.J., Naval, J., Schmitt-Verhulst, A.M., Boyer, C. y Anel, A. </strong><br>
            <span class="Estilo21">Differential implication of protein kinase C isoforms in CTL degranulation and in TCR-induced Fas ligand expression. </span><br>
          Int. Immunol., 15 : 1441-1450, 2003 (<span class="Estilo23">Pardo.03.Int. Immunol.</span>)</p>
          <p class="Estilo8"><strong>Pardo, J., Bosque, A., Brehm, R., Wallich, R., M&uuml;llbacher, A., Naval, J., Anel, A. y Simon, M.M. </strong><br>
            <span class="Estilo21">Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis. </span><br>
          J. Cell Biol., 167 : 457-468. 2004. (<span class="Estilo23">Pardo.04.J. Cell Biol.</span>)</p>
          <p class="Estilo8"><strong>Mart&iacute;n-Fern&aacute;ndez, J.M., Cabanillas, J.A., Rivero-Carmena, R., Lacasa, E., Pardo, J., Anel, A., Rodr&iacute;guez- Duque, P.R., Merino, F. and Regueiro, J.R.</strong> <br>
            <span class="Estilo21">Modelling Chediak-Higashi Syndrome Cytolytic Lymphocytes by <em>Herpesvirus Saimiri </em> Transformation. </span><br>
          J. Leukoc. Biol., en prensa. 2005.</p>
          <p class="Estilo8"><strong>Iturralde, M., Pardo, J., Barrio, G., Lacasa, E., Alava, M.A., Pi&ntilde;eiro, A., Naval, J. y Anel, A. </strong><br>
            <span class="Estilo21">Characterization of the lypolitic pathways that mediate free fatty acids release during Fas-induced apoptosis. </span><br>
          Apoptosis, en prensa <em>, </em>2005. </p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><b><font color="#000000">Anel, A., Gamen, S., Alava, M.A., Schmitt-Verhulst, A.M., Pi&ntilde;eiro, 
              A. y Naval, J. </font></b><i><b><font face="Times New Roman, Times, serif">Inhibition 
              of </font></b></i><b><font face="Tw Cen MT, Arial Narrow, Arial"><font size="3">CPP32-like 
              proteases prevents granzyme B- and Fas-, but not granzyme A-based 
              cytotoxicity exerted by CTL clones.</font></font></b> <br>
            <font color="#000000">J. Immunol., 158 : 1999-2006, 1997</font></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000">.</font><font face="Tw Cen MT, Arial Narrow" size="2" color="#0033CC"> 
            <a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860"><font color="#FF6600">PDF 
            &quot;Anel&quot;</font></a></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>Gamen, S., Hanson, D.A., Kaspar, A., Naval, J., Krensky, A.M. y Anel, 
            A.</b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><br>
            <b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">Granulysin-induced 
            apoptosis. I. Involvement of at least two distinct pathways. </font></b><br>
            <font color="#000000">J. Immunol., 161 : 1758-1764, 1998</font></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000">.</font><font face="Tw Cen MT, Arial Narrow" size="2" color="#0033CC"> 
            <a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860"><font color="#FF6600">pdf 
            &quot;Gamen&quot;</font></a></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>Anel, A. y Naval, J. </b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><br>
            <font face="Times New Roman, Times, serif"><b><font size="3" face="Tw Cen MT, Arial Narrow, Arial">Cell-mediated 
            cytotoxicity and cell death receptors, </font></b></font><br>
            <font color="#000000">en &quot;Apoptosis : A practical approach&quot;, 
            (Studzinski, G., ed.). pp. 81-103.<br>
            Practical Approach Series. Oxford University Press. Oxford, 1999.</font></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><b><font color="#000000">Kaspar, A., Okada, S., Kumar, J., Poulain, F.R., Drouvalakis, K.A., 
            Kelekar, A., Hanson, D.A., Kluck, R.M., Hitoshi, Y., Johnson, D.E., 
            Froelich, C., Thompson, C.B., Newmeyer, D.D., Anel, A., Clayberger, 
            C. y Krensky, A.M. </font></b><br>
            <b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">A distinct 
            pathway of cell-mediated apoptosis initiated by granulysin.</font></b> 
            <br>
            <font color="#000000">J. Immunol., 167 : 350-356. 2001.</font> </font><font face="Tw Cen MT, Arial Narrow" size="2" color="#0033CC"><a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860"><font color="#FF6600">pdf 
            &quot;Kaspar&quot;</font></a></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><b><font color="#000000">Pardo, J., P&eacute;rez-Gal&aacute;n, P., Gamen, S., Marzo, I., Monle&oacute;n, 
            I., Kaspar, A.A., Sus&iacute;n, S.A., Kroemer, G., Krensky, A.M., 
            Naval, J. y Anel, A. </font></b><br>
            <b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">A role of 
            the mitochondrial apoptosis-inducing factor (AIF) in granulysin-induced<br>
            apoptosis. </font></b><br>
            <font color="#000000"> J. Immunol., 167 : 1222-1229. 2001. <a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860"></a></font><a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860"><font color="#FF6600">pdf 
            &quot;Pardo&quot;</font></a></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>Pardo, J., Balkow, S., Anel, A. y Simon M.</b></font><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><br>
            <b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">The diferential 
            contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated 
            apoptosis es determined by the quality of target cells.</font></b><br>
            <font color="#000000">Eur. J. Immunol. 2002. 32:1980-1985.</font> 
            <a href="http://cvu.rediris.es/bscw/bscw.cgi/d276435/EJI.pdf"><font color="#FF6600">pdf 
            &quot;EJI&quot;</font></a></font></p>
          <p><span class="Estilo20"><font color="#000000" size="2"><b>Pardo, J., Balkow, S., Anel, A. y Simon, M.M. </b></font><br>
            <font size="3" color="#009999"><b>Granzymes 
            are critically involved in NK-mediated control of RMA-S tumor growth 
            in vivo. </b></font></span><br>
            <span class="Estilo20"><font size="2">Eur. 
            J. Immunol., 32 : 2881-2886, 2002. 


          <span class="Estilo23">Pardo.02.Eur. J. Immunol.II</span></font></span></p>
          <p><font size="2"><br>
          </font><font face="Tw Cen MT, Arial Narrow" size="2" color="#003366"><b><font size="3">LINEA 
            4</font></b></font></p>
          <p class="Estilo8"><strong>Iturralde, M., Monle&oacute;n, I., Aguil&oacute;, J.I., Mart&iacute;nez-Lorenzo, M.J., Lampreave, F., Pi&ntilde;eiro, A. Naval, J., Anel, A. y Alava, M.A. </strong><br>
            <span class="Estilo21">Altered cellular protein expression pattern correlates with delayed doxorubicin-induced apoptosis in highly proliferative Jurkat cell sublines</span><br>
          &quot;Recent Research Developments in Immunology, vol. 5&quot; (Pandalai, S.G., ed.), en prensa, Research Signpost. Trivandrum. 2005. </p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>Mart&iacute;nez-Lorenzo, M.J., Gamen, S., Etxeberr&iacute;a, J., Lasierra, 
              P., Larrad,<br>
            L., Pi&ntilde;eiro, A., Anel, A., Naval, J. y Alava, M.A. </b><br>
            <font face="Times New Roman, Times, serif" color="#009999"><b><font face="Tw Cen MT, Arial Narrow, Arial" size="3">Resistance 
              to apoptosis correlates with a highly proliferative phenotype and 
            loss of Fas and CPP32 (caspase-3) expression in human leukemias.</font></b></font> 
            <br>
            Int. J. Cancer, 75 : 473-481, 1998</font><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999">.</font><font face="Tw Cen MT, Arial Narrow" size="2" color="#0033CC"> 
            <a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860"><font color="#FF6600">pdf 
            &quot;CPP32-&quot;</font></a></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><b>Mart&iacute;nez-Lorenzo, M. J., Anel, A., Monle&oacute;n, I., Sierra, 
            J.J., Pi&ntilde;eiro,<br>
            A., Naval, J. y Alava, M. A. </b><br>
            <font face="Times New Roman, Times, serif" color="#009999"><b><font size="3" face="Tw Cen MT, Arial Narrow, Arial">Tyrosine 
            phosphorylation of the p85 subunit of phosphatidylinositol 3-kinase 
            correlates with high proliferation rates in sublines derived from 
            the Jurkat leukemia.</font></b></font> <br>
            Int. J. Biochem. Cell Biol., 32: 435-445, 2000.</font><font face="Tw Cen MT, Arial Narrow" size="2" color="#0033CC"> 
            <a href="http://cvu.rediris.es/bscw/bscw.cgi/0/267860"><font color="#FF6600">pdf 
            &quot;p85&quot;</font></a></font></p>
          <p><font face="Tw Cen MT, Arial Narrow" size="2" color="#009999"><b><font color="#000000">Monle&oacute;n, I., Iturralde, M., Mart&iacute;nez-Lorenzo, M.J., 
            Monteagudo, L., Lasierra, P., Larrad, L., Pi&ntilde;eiro, A., Naval, 
            J., Alava, M.A. and Anel, A.</font></b> </font><font face="Tw Cen MT, Arial Narrow" size="2" color="#000000"><br>
            <font face="Times New Roman, Times, serif" color="#009999"><b><font size="3" face="Tw Cen MT, Arial Narrow, Arial">Lack 
            of Fas/CD95 Surface Expression in Highly Proliferative Leukemic Cell 
            Lines Correlates with Loss of CtBP/BARS and Redirection of the Protein 
            toward Giant Lysosomal Structures.</font></b></font><br>
            Cell Growth &amp; Differentiation. Vol. 13,315-324, July 2002. <font color="#003399"><a href="http://cvu.rediris.es/bscw/bscw.cgi/d276446/MonleonCGD.pdf"><font color="#FF6600">pdf 
            MonleonCGD</font></a></font></font></p>
          <p align="right"><font face="Tw Cen MT, Arial Narrow" size="2" color="#336666"><img src="probando/arriba.gif" width="15" height="21" border="0" usemap="#Map3Map">
            <map name="Map3Map">
              <area shape="rect" coords="0,1,21,21" href="#subir" alt="Subir" title="Subir">
            </map>
            <br>
            <a name="d"></a> </font></p>
          <hr>
          <p><br>
            <span class="Estilo24"><font face="Tw Cen MT, Arial Narrow, Arial" size="4"><b>Proyectos 
            de Investigaci&oacute;n y Contratos </b></font></span></p>
          <p class="Estilo8"><span class="Estilo21">Caracterizaci&oacute;n de las rutas de apoptosis en neoplasias hematol&oacute;gicas humanas. Aplicaci&oacute;n a la identificaci&oacute;n de nuevos factores de pron&oacute;stico y mejora del tratamiento de la LLC-B y el MM </span><br>
          <span class="Estilo4"><strong>Entidad financiadora : </strong>Instituto de Salud </span>Carlos III <br>
          <strong>Duraci&oacute;n,</strong> desde 2003 hasta 2005. <br>
          <strong>Investigador responsable :</strong> Dr. Javier Naval</p>
          <p class="Estilo8"><span class="Estilo21">Red Tem&aacute;tica Mieloma m&uacute;ltiple y otras gammapat&iacute;as. De la g&eacute;nesis a la terap&eacute;utica </span><br>
            <strong>Entidad financiadora : </strong>Instituto de Salud Carlos III <br>
            <strong>Duraci&oacute;n,</strong> desde 2003 hasta 2005. <br>
            <strong>Investigador responsable:</strong> Dr. Jes&uacute;s Santamar&iacute;a, Centro de Investigaci&oacute;n del C&aacute;ncer, Salamanca</p>
          <p class="Estilo8"><span class="Estilo21"><strong>Apoptosis, inmunidad y c&aacute;ncer </strong></span><br>
            <strong>Entidad financiadora : </strong>Gobierno de Arag&oacute;n. Reconocimiento como Grupo de Excelencia en Investigaci&oacute;n. <br>
            <strong>Duraci&oacute;n: </strong>2003-2005. <br>
            <strong>Investigador responsable :</strong> Dr. Andr&eacute;s Pi&ntilde;eiro</p>
          <p align="left" class="Estilo8"><span class="Estilo21">Estudio de los mecanismos de inducci&oacute;n de apoptosis por los sistemas perforina/granzima A y perforina/granzima B utilizando linfocitos T citot&oacute;xicos procedentes de ratones &quot;knockout&quot; para la granzima B &oacute; A. Relevancia para el control del desarrollo tumoral <em>in vivo </em>. </span><br>
            <strong>Entidad financiadora : </strong>Acci&oacute;n Integrada Hispano-Alemana <br>
            <strong>Duraci&oacute;n : </strong>2003-2004. <br>
            <strong>Investigadores responsables : </strong>Drs. Alberto Anel y Markus M. Simon</p>
          <p class="Estilo8"><span class="Estilo21"><strong>Funci&oacute;n efectora y regulaci&oacute;n de la respuesta inmunitaria mediada por c&eacute;lulas T. Aplicaci&oacute;n a patolog&iacute;as tumorales, infecciosas y autoinmunes . </strong></span><br>
            <strong>Entidad financiadora : </strong>Ministerio de Educaci&oacute;n y Ciencia. Programa Nacional de Biomedicina. <br>
            <strong>Duraci&oacute;n,</strong> desde 2005 hasta 2007. <br>
          <span class="Estilo8"><strong>Investigador responsable :</strong> Dr. Alberto Anel </span></p>
          <p><font face="Tw Cen MT, Arial Narrow, Arial" size="2"><b><font color="#009999" size="3">Relevancia del sistema Fas/ligando de Fas y de las caspasas en la 
              regulaci&oacute;n y funci&oacute;n antitumoral del sistema inmunitario 
              y en el mecanismo de apoptosis inducida por drogas quimioterap&eacute;uticas.</font></b><br>
            <b>Entidad financiadora:</b> Fondo de Investigaciones Sanitarias (FIS). 
            <br>
            <b>Duraci&oacute;n: </b>desde 1999 hasta 2001.<br>
            <b>Investigador responsable:</b> Dr. Javier Naval</font></p>
          <p><font face="Tw Cen MT, Arial Narrow, Arial" size="2"><b><font color="#009999" size="3">Apoptosis y muerte programada de las c&eacute;lulas: mecanismos moleculares 
            y aplicaciones en biotecnolog&iacute;a y agricultura.</font></b><br>
            <b>Entidad financiadora:</b> Uni&oacute;n Europea, Acci&oacute;n COST<br>
            <b>Duraci&oacute;n,</b> desde 2000 a 2004.<br>
            Participaci&oacute;n de los Drs. Javier Naval y Alberto Anel<br>
            <b><font color="#009999"><br>
            <font size="3">Utilizaci&oacute;n de prote&iacute;nas implicadas 
            en la apoptosis (Fas/ligando de Fas, Bcl-2, caspasas) como marcadores 
            moleculares de pron&oacute;stico o evoluci&oacute;n. Aplicaci&oacute;n 
            a dos patolog&Igrave;as de incidencia significativa en Arag&oacute;n: 
            la artritis reumatoide y la leucemia linf&aacute;tica cr&oacute;nica.</font></font></b><br>
            <b>Entidad financiadora:</b> Gobierno de Arag&oacute;n. <br>
            <b>Duraci&oacute;n</b>, desde 2001 hasta 2003.<br>
            <b>Investigador responsable:</b> Dr. Alberto Anel </font></p>
          <p><font face="Tw Cen MT, Arial Narrow, Arial" size="2" color="#009999"><b><font size="3">Mecanismos apopt&oacute;ticos implicados en la regulaci&oacute;n del 
            sistema inmunitario y en su funci&oacute;n efectora. Aplicaci&oacute;n 
            a patolog&iacute;as autoinmunes.</font></b></font><font face="Tw Cen MT, Arial Narrow, Arial" size="2"><br>
            <b>Entidad financiadora:</b> Ministerio de Ciencia y Tecnolog&iacute;a. 
            Programa Nacional de Biomedicina.<br>
            <b>Duraci&oacute;n,</b> desde 2002 hasta 2004.<br>
            <b>Investigador responsable:</b> Dr. Alberto Anel </font></p>
          <p><font face="Tw Cen MT, Arial Narrow, Arial" size="2"><b><font color="#009999" size="3">Caracterizaci&oacute;n molecular de las alteraciones en los procesos 
            de se&ntilde;alizaci&oacute;n &uml;inter&uml; e &uml;intracelular&uml; 
            en l&iacute;neas celulares resistentes a la apoptosis con fenotipo 
            altamente proliferativo, generadas a partir de la leucemia humana 
            Jurkat.</font></b><br>
            <b>Entidad financiadora:</b> Ministerio de Ciencia y Tecnolog&iacute;a. 
            Programa Nacional de Biomedicina.<br>
            <b>Duraci&oacute;n,</b> desde 2002 hasta 2004.<br>
            <b>Investigadora responsable:</b> Dra. Mar&iacute;a Angeles Alava</font></p>
          <p><font face="Tw Cen MT, Arial Narrow, Arial" size="2" color="#009999"><b><font size="3">Papel de las prote&iacute;nas de la superfamilia Bcl-2, las caspasas 
            y AIF en la apoptosis inducida por drogas citot&oacute;xicas en leucemias 
            y linformas humanos. </font></b></font><font face="Tw Cen MT, Arial Narrow, Arial" size="2"><br>
            <b>Entidad financiadora:</b> Ministerio de Ciencia y Tecnolog&iacute;a. 
            Programa &quot;Ram&oacute;n y Cajal&quot;.<br>
            <b>Duraci&oacute;n,</b> desde 2002 a 2005. <br>
            <b>Investigadora responsable:</b> Dra. Isabel Marzo</font></p>
          <p align="right"><img src="Imagenes/arriba.gif" width="15" height="21" usemap="#Map3Map2" border="0">
            <map name="Map3Map2">
              <area shape="rect" coords="0,1,21,21" href="#subir" alt="Subir" title="Subir">
            </map> 
            <br>
            <a name="e"></a> </p>
          <hr>
          <p><span class="Estilo24"><font face="Tw Cen MT, Arial Narrow, Arial" size="4"><b>Tesis 
            Doctorales</b></font></span><br>
            <br>
            <font face="Tw Cen MT, Arial Narrow, Arial" size="3"><b><font color="#003366">Calificadas</font></b></font></p>
          <p class="Estilo8"><span class="Estilo9">Mecanismos implicados en la regulaci&oacute;n homeost&aacute;tica y en la resistencia a la apoptosis de c&eacute;lulas T humanas normales y tumorales</span> <br>
            <strong>DOCTORANDO:</strong> Inmaculada Monel&oacute;n Brau <br>
          <strong>DIRECTORES:</strong> Drs. Mar&iacute;a Angeles Alava y Alberto Anel <br>
          <strong>FECHA:</strong> 2002 <br>
          <strong>CALIFICACION:</strong> Sobresaliente &quot;cum laude&quot; (Premio Extraordinario de Doctorado 2003) </p>
          <p class="Estilo8"><span class="Estilo9">Caracterizaci&oacute;n de los mecanismos de apoptosis inducida por los f&aacute;rmacos antitumorales doxorrubicina y cladribina en leucemias humanas. </span><br>
            <strong>DOCTORANDO:</strong> Patricia P&eacute;rez Gal&aacute;n <br>
            <strong>DIRECTORES:</strong> Drs. Javier Naval y Alberto Anel <br>
            <strong>CALIFICACION : </strong>Sobresaliente &quot;cum laude&quot;. 2003 (Premio Extraordinario de Doctorado 2004) </p>
          <p class="Estilo8"><span class="Estilo9">Mecanismos citol&iacute;ticos de los linfocitos T citot&oacute;xicos : perforina/granzimas, granulisina e inducci&oacute;n del ligando de Fas. </span><br>
            <strong>DOCTORANDO: </strong>Juli&aacute;n Pardo Jimeno <br>
            <strong>DIRECTORES: </strong>Drs. Alberto Anel y Javier Naval <br>
            <strong>CALIFICACION :</strong> Sobresaliente &quot;cum laude&quot;. 2003 (Premio Extraordinario de Doctorado 2005) </p>
          <p class="Estilo8">&nbsp;            </p>
          <p class="Estilo8"><font face="Tw Cen MT, Arial Narrow, Arial" size="2"><font size="3" color="#003366"><b>En curso</b></font><br>
              <span class="Estilo9"><br>
              </span></font><span class="Estilo9">Mecanismos implicados en la regulaci&oacute;n de la activaci&oacute;n de los linfocitos T humanos </span><br>
              <strong>DOCTORANDO:</strong> Alberto Bosque Pardos <br>
          <strong>DIRECTORES:</strong> Drs. Alberto Anel y Javier Naval <br>
          <strong>FECHA:</strong> iniciada en 2002, en curso </p>
          <p class="Estilo8"><span class="Estilo9">Generaci&oacute;n de antisueros contra ligandos mortales por inyecci&oacute;n de cDNA. Caracterizaci&oacute;n de un segundo receptor para APO3 ligando/TWEAK </span><br>
            <strong>DOCTORANDO:</strong> Clara Diestre Mart&iacute;n <br>
          <strong>DIRECTORES: </strong>Drs. Alberto Anel y Mar&iacute;a Jos&eacute; Mart&iacute;nez-Lorenzo <br>
          <strong>FECHA:</strong> iniciada en 2002, en curso </p>
          <p class="Estilo8"><span class="Estilo9">Mecanismo de apoptosis inducida por inhibidores de farnesiltransferasas en c&eacute;lulas de mieloma humano </span><br>
            <strong>DOCTORANDO:</strong> Mar&iacute;a G&oacute;mez Benito <br>
          <strong>DIRECTORES: </strong>Drs. Javier Naval e Isabel Marzo <br>
          <strong>FECHA:</strong> iniciada en 2003, en curso </p>
          <p class="Estilo8"><span class="Estilo9">Disecci&oacute;n molecular de la etapa de inducci&oacute;n de apoptosis por la ruta end&oacute;gena en c&eacute;lulas leuc&eacute;micas humanas </span><br>
            <strong>DOCTORANDO: </strong>Nuria L&oacute;pez Royuela <br>
          <strong>DIRECTORES:</strong> Drs. Javier Naval e Isabel Marzo <br>
          <strong>FECHA: </strong>iniciada en 2004, en curso </p>
          <p class="Estilo8"><span class="Estilo4"></span><font face="Tw Cen MT, Arial Narrow, Arial" size="2"><br>
            </font></p>
          <p align="right"> <a href="#subir"><img src="Imagenes/arriba.gif" width="15" height="21" border="0" usemap="#Map6"></a><br>
          </p>
        </blockquote>
      </td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="2" valign="middle" align="center" bgcolor="#000000"><img src="Imagenes/fasL-02.jpg" width="99" height="80" alt="FasL en c&eacute;lulas Jukart"></td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="2" valign="middle" align="center" bgcolor="#000000"><img src="Imagenes/APO2L-01.jpg" width="101" height="87" alt="APO2L en c&eacute;lulas Jurkat"></td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="2" valign="middle" bgcolor="#000000" align="center"><img src="Imagenes/FasLAPO2L-01.jpg" width="100" height="87" alt="Colocalizaci&oacute;n FasL-APO2L en c&eacute;lulas Jurkat"> 
      </td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="2" valign="top" bgcolor="#000000">&nbsp;</td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="2" valign="top" bgcolor="#000000" align="center"><img src="Imagenes/FasLJurkat-01.jpg" width="76" height="72" alt="Secuencia Ausencia de colocalizaci&oacute;n de Fas/CD95 con el marcador lisosomal lamp-1 en la leucemia 01 (Fas L)"></td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="2" valign="middle" bgcolor="#000000" align="center"><img src="Imagenes/lamp1-Jurkat.jpg" width="77" height="72" alt="Secuencia Ausencia de colocalizaci&oacute;n de Fas/CD95 con el marcador lisosomal lamp-1 en la leucemia 02 (lamp 1)"></td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="2" valign="top" bgcolor="#000000" align="center"><img src="Imagenes/fasLLamp1Jurkat.jpg" width="76" height="71" alt="Secuencia Ausencia de colocalizaci&oacute;n de Fas/CD95 con el marcador lisosomal lamp-1 en la leucemia  03 (Fas L + lamp 1)"></td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="2" valign="top" bgcolor="#000000" align="center"><img src="Imagenes/Jurkat-ws-FasL.jpg" width="77" height="112" alt="Secuencia colocalizaci&oacute;n completa en  la subl&iacute;nea hiperproliferativa derivada, Jurkat-ws (Fas L)"></td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="2" valign="middle" bgcolor="#000000" align="center"><img src="Imagenes/Jurkat-ws-lamp1.jpg" width="78" height="112" alt="Secuencia colocalizaci&oacute;n completa en  la subl&iacute;nea hiperproliferativa derivada, Jurkat-ws (lamp 1)"></td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="2" valign="top" bgcolor="#000000" align="center"><img src="Imagenes/Jurkat-ws-CoFasLlamp1.jpg" width="77" height="112" alt="Secuencia colocalizaci&oacute;n completa en  la subl&iacute;nea hiperproliferativa derivada, Jurkat-ws (Amarillo= Colocalizaci&oacute;n fas L + lamp 1)"></td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="2" valign="top" bgcolor="#000000">&nbsp;</td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="2" valign="top" bgcolor="#000000" align="center"><br>
        <br>
        <br>
        <img src="Imagenes/microvesiculasAPO2LTRAIL.jpg" width="115" height="353" alt="Secreci&oacute;n de microves&iacute;culas con marcaje exclusivo de APO2L/TRAIL tras estimulaci&oacute;n de blastos T"></td>
      <td></td>
    </tr>
    <tr> 
      <td valign="top" colspan="2" bgcolor="#000000">&nbsp;</td>
      <td></td>
    </tr>
    <tr> 
      <td colspan="8" valign="top"> 
        <table width="762" border="0" cellspacing="0" cellpadding="0" bgcolor="#000000">
          <tr> 
            <td width="254" height="42" valign="middle" align="center"><object classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" codebase="http://download.macromedia.com/pub/shockwave/cabs/flash/swflash.cab#version=5,0,0,0" width="95" height="15">
                <param name="BGCOLOR" value="#000000">
                <param name="BASE" value=".">
                <param name=movie value="inmuno.swf">
                <param name=quality value=high>
                <embed src="inmuno.swf" quality=high pluginspage="http://www.macromedia.com/shockwave/download/index.cgi?P1_Prod_Version=ShockwaveFlash" type="application/x-shockwave-flash" width="95" height="15" bgcolor="#000000" base=".">
                </embed> 
              </object></td>
            <td width="254" valign="top" align="center">&nbsp;</td>
            <td width="254" valign="middle" align="center"><a href="#" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('arribaar','','Imagenes/arribaaron.jpg',1)"><img name="arribaar" border="0" src="Imagenes/arribaar.jpg" width="21" height="29"></a><br>
              <font face="Tw Cen MT, Arial Narrow, Arial" size="1" color="#003366"><font color="#999999"><b><font color="#666666">Ir 
              al principio</font></b></font></font></td>
          </tr>
          <tr> 
            <td height="1"></td>
            <td></td>
            <td></td>
          </tr>
        </table>
      </td>
      <td></td>
    </tr>
    <tr> 
      <td></td>
      <td width="17"></td>
      <td></td>
      <td></td>
      <td width="66"></td>
      <td width="123"></td>
      <td></td>
      <td></td>
      <td></td>
    </tr>
  </table>
</div>
<hr width="762" align="center">
<map name="Map3"> 
  <area shape="rect" coords="0,1,21,21" href="#subir" alt="Subir" title="Subir">
</map>
<map name="Map4"> 
  <area shape="rect" coords="522,3,700,29" href="integrantes.htm" alt="Ir a principal de integrantes" title="Ir a principal de integrantes">
</map>
<map name="Map5"> 
  <area shape="rect" coords="5,7,135,59" href="index.htm" alt="Ir a la p&aacute;gina principal" title="Ir a la p&aacute;gina principal">
</map>
<map name="Map6"><area shape="rect" coords="0,1,21,21" href="#subir" alt="Subir" title="Subir"> 
  <area shape="rect" coords="0,0,26,31" href="#" alt="Subir" title="Subir">
</map>
<map name="Map8">
</map>
<map name="Map2"> 
  <area shape="rect" coords="1,0,23,31" href="#subir" alt="Subir" title="Subir">
</map>
</body>
</html>
